Introduction {#S1}
============

Human T cell leukemia virus type 1 (HTLV-1) belongs to the Retroviridae family, the orthoretrovirinae subfamily and to the deltaretrovirus genus ([@B147]). HTLV-1 has been recognized as a causative agent of two important diseases, HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma (ATL) ([@B217]; [@B51]; [@B142]). The virus not only induces HAM/TSP and ATL in a small proportion of HTLV-1 carriers, but it is also associated with several diseases such as HTLV-1 associated arthropathy (HAAP), exocrinopathy, HTLV-1 uveitis (HU), cutaneous T cell lymphoma (CTCL), dermatitis, Graves' disease, lymphadenitis, polymyositis, and chronic respiratory diseases ([@B87]; [@B53]; [@B123]; [@B140]; [@B95]; [@B59]; [@B122]; [@B141]; [@B208]).

The exact mechanism of the development and pathogenesis of HAM/TSP and ATL among less than 3--5% of HTLV-1 carriers has not fully understood. However, it has been reported that genetic background such as human leukocyte antigen (HLA) and HTLV-1 genomic variation are associated with the risk of HAM/TSP among HTLV-1 carriers ([@B110]; [@B78]; [@B48]; [@B160]; [@B152]). The major criteria that differ HAM/TSP patients from HTLV-1-infected ACs are high titers of anti-HTLV-1 antibody, increased proviral loads, higher frequency of HTLV-1 specific cytotoxic T lymphocytes (CTLs), and elevation in activated lymphocytes ([@B88]; [@B42]; [@B133]). Evidence also suggests viral and environmental factors, the efficiency of immune response and the genetic background of the HTLV-1 infected individual affect the outcome of HTLV-1 infection.

In HAM/TSP patients, high CTL responses may lead to the production of inflammatory cytokines and bystander damage. Based on this criterion, HTLV-1 specific CD8^+^ clones in HAM/TSP patients produce a wide variety of members of cyto/chemokine family, such as Interferon-gamma (IFN-γ), Tumor necrosis factor-alpha (TNF-α), Interleukin (IL)-2, Macrophage inflammatory protein 1-alpha (MIP-1α)/CCL3, beta (MIP-1β)/CCL4, and Matrix metalloproteinase-9 (MMP-9), which promote the inflammatory response ([@B42]). HTLV-1 infected cells have the potential to produce IFN-γ and migration toward tissues, including central nervous system (CNS), which may induce a harmful non-specific immune response within the CNS ([@B42]). Furthermore, Tax-inducible production of TNF-α, IL-1β, and IL-6 by macrophages and microglia may enhance the proinflammatory response in the CNS ([@B52]; [@B4]).

The immune response and the number of infected cells in the cerebrospinal fluid (CSF) are important factors for the induction of chronic inflammation observed in the CNS of HAM/TSP patients ([@B16]; [@B91]). Plasma level of CCL24 that is related to type 2 immune response has been reported to be reduced in HAM/TSP. The low CCL24 plasma levels support the theory of enhanced type 1 immune response in HAM/TSP patients ([@B56]). It seems that the number of chemokines and their receptors in the peripheral blood and in the site of inflammation act as a risk factor for the development of HAM/TSP. Previous studies have revealed that chemokines and their receptors play a critical role in HTLV-1 infection and migration of HTLV-1 infected cells into the CNS through the blood-brain barrier (BBB); playing an essential role in the onset of HAM/TSP ([@B7]). It was also shown that cerebral endothelial cells are susceptible to HTLV-1 infection, leading to HTLV-1 passage through the BBB and subsequent BBB breakdown ([@B3], [@B2]).

ATL is a peripheral T-cell malignancy with poor prognosis ([@B85]). In contrast to HAM/TSP, ATL patients exhibit immunosuppressive conditions ([@B198]; [@B27]; [@B180]). The immune system in ATL patients is directly suppressed by cytokines such as IL-10 and transforming growth factor-beta (TGF-B), which might be attributed to IL-10 production by Tax and HTLV-1 basic leucine zipper factor (HBZ) promotion ([@B124]; [@B68]; [@B114]).

Studies have shown that ATL cells obtained from peripheral blood and skin tumors of ATL patients are CD4^+^CD25^+^ FOxp3^low^ and express cytotoxic T lymphocyte-associated antigen (CTLA)-4 with no regulatory activity ([@B178]; [@B168]). Therefore, the pattern of cytokine production provides evidence for the pathogenesis of HTLV-1 associated diseases. The other factor, which is involved in the migration and tissue microenvironmental localization of lymphocytes, is adhesion molecules that are expressed on the surface of certain cells ([@B43]; [@B15]). Furthermore, chemokines and their associated receptors are also involved in the pathogenesis of ATL as it infiltrates ATL cells into the lymph nodes, spleen, liver, skin and GIT ([@B61]; [@B16]; [@B91]). Here, we discuss the role of chemokines and their receptors in the development and pathogenesis of HAM/TSP, ATL and other HTLV-1 related diseases.

Chemokines and Their Receptors {#S2}
==============================

Chemokines or chemotactic cytokines are a group of small molecules (weighing ∼8--14 kDa) which regulate migration and trafficking of various types of immune cells through interactions with a subset of cell surface seven-transmembrane G protein-coupled receptors (GPCRs) ([@B223]). To date, about 50 chemokines and 20 chemokine receptors have been identified in humans ([@B25]). Based on a new classification, chemokine ligands and receptors are named as 'L' and 'R,' respectively ([@B223]). Chemokines play pivotal roles in the development, homeostasis, and functions of the immune system ([@B223]). They mainly act to traffic monocytes, lymphocytes, neutrophils, and eosinophils to the site of injury, infection, and inflammation, and thus play an important role in host defense mechanisms ([@B223]). Chemokines are involved in the pathobiology of chronic inflammations, autoimmune diseases, tumorigenesis, and tumor metastasis. In fact, a disease often occurs when the physiological role of chemokines is disrupted ([@B154]).

In addition to their role in the immune system, chemokines also have a wide range of effects on many different cell types including various types of the CNS or endothelial cells, where they result in either angiogenesis or angiostasis ([@B184]; [@B109]). They are involved in cell migration during embryogenesis and also play important roles in wound healing, angiogenesis/angiostasis and tumor development and metastasis ([@B116]; [@B112]; [@B101]; [@B215]; [@B28]; [@B73]). The role played by chemokine/receptor axes in tumor pathophysiology is complex as some chemokines enhance tumor development and metastasis, while others associate with an effective anti-tumor immune response ([@B181]).

On the basis of the arrangement of the two N-terminal cysteine residues in their biochemical structure, chemokines are further divided into four major subfamilies, CXC, CX3C, CC, and C, depending on whether the first two cysteine residues have either one or more amino acids between them (CXC, CX3C) or are adjacent (CC) ([@B118]). CXC chemokines have the ability to activate and attract neutrophils and T lymphocytes, while CC chemokines are effective on multiple leukocyte subtypes including monocytes, eosinophils, T lymphocytes, basophils, dendritic cells (DCs), natural killer (NK) cells, and neutrophils. CX3C (Fraktaline) induces the migration of T cells, NK cells, and monocytes ([@B106]; [@B98]). Since the receptors for CC and CXC chemokines determine the viral tropism and mediate the efficient entry of human immunodeficiency virus (HIV) into host cells, CC and CXC chemokines could suppress HIV infection ([@B143]). CC chemokines mostly inhibit the entry and replication of macrophage-tropic strains; nonetheless, CXC chemokines mostly inhibit the entry of T-tropic strains ([@B143]).

According to their function and pattern of expression, chemokines have also been classified into homeostatic and inflammatory groups or both. The homeostatic chemokines are constitutively expressed and important in many physiological processes and are involved in normal circulation and trafficking of leukocytes in lymph nodes and thymus, while the production of inflammatory group is induced by infection or other proinflammatory stimuli resulting in recruitment of leukocytes to the insulted regions, in particular, due to infection ([@B36]; [@B175]).

Chemokine receptors are subdivided into CCR, CXCR, CX3CR, and CR based on the ligand to which they bind. The interesting fact about the chemokine receptors is the great level of redundancy observed in their effects on targets in which most of them can bind to several chemokines and most chemokines utilize more than one receptor ([@B223]). During viral infection, the expression of CC chemokines is more prevalent than CXC chemokines ([@B117]; [@B38]). CCL3 and CCL5 appear to be mostly related to viral infections ([@B157]; [@B26]; [@B57]; [@B41]). Among CXCL chemokines which are produced during viral infection, CXCL10 expression is observed in many viral infections ([@B39]; [@B57]; [@B103]; [@B145]). CCL2 and CXCL10 are expressed at large measures during human viral meningitis and influenza infections, while in the case of hepatitis C virus (HCV), CCL5 and CXCL9 are more expressed ([@B96]; [@B39]; [@B57]; [@B8]).

Chemokines and HTLV-1 Viral Transcriptional Regulators {#S3}
======================================================

HTLV-1 Tax and HBZ viral products are associated with oncogenic transformation and ATL pathogenesis ([@B149]; [@B187]; [@B169]). Tax is a key regulatory protein encoded by the pX region of the HTLV-1 genome, while HBZ is encoded by the antisense strand of the virus genome ([@B135]; [@B97]; [@B29]). Tax and HBZ regulate transcription of viral proteins, host factors and cellular signaling pathways, resulting in development of HTLV-1 associated diseases ([@B35]; [@B221]). The HTLV-1 Tax protein has been known as a potent activator of a variety of transcription factors including NF-kB, CREB, SRF, and AP-1 ([@B47], [@B45], [@B46]; [@B21]; [@B77]). It was shown that the transcription factors NF-kB and AP-1 are involved in Tax-mediated transactivation of IL-8 ([@B126]). Extracellular Tax has the ability to enhance maturation of human monocyte-derived DCs and exerts changes in their function, which is accompanied by constant antigen presentation to T cells, leading to uncontrolled T cell proliferation and disease progression ([@B75]). Furthermore, Tax induces the production of proinflammatory cytokines and chemokines involved in the activation of DCs ([@B75]). The production of CXCL10, CCL1, CCL3, and CCL4 is induced by Tax ([@B14]). CCL3 and CCL4 are among CC chemokines that attract DCs into the lymph nodes and play an important role in the effector phase of lymphocyte response and are capable of recruiting T cells with regulatory properties to the inflammation site ([@B163]; [@B130]; [@B75]). CCL20/MIP-3α is a CC chemokine with a crucial role in the initiation of inflammation ([@B67]).

It has been reported that Tax elevates the levels of CCL20 mRNA in HTLV-1 infected cell lines and human T cell lines. The specific receptor for this chemokine is CCR6, which is also increased in HTLV-1 infected cell lines suggesting an autocrine/paracrine mechanism for the development of HTLV-1-associated diseases ([@B13]; [@B67]). Among various leukocyte subsets, CCR6 was detected and strongly up-regulated by IL-2 in lymphocytes (CD4^+^ and CD8^+^ T cells and B cells) but not in NK cells, monocytes, or granulocytes ([@B13]). CCL20 is responsible for chemo-attraction of effector/memory T cells and B cells through its receptor, CCR6 ([@B13]). Furthermore, CCL20 recruits immature DCs to the inflammation site and is crucial in the regulation of inflammation toward the skin and mucosal surfaces under homeostatic and inflammatory conditions, as well as in pathological conditions, including cancer and autoimmune disorders such as rheumatoid arthritis ([@B111]; [@B173]).

Tax induces CC chemokines including CCL5, CCL4 and, CCL3 in cultured peripheral blood mononuclear cells (PBMCs) from uninfected subjects ([@B17], [@B18]). These chemokines are known as HIV inhibitory factors and expression of CCL5, CCL4, CCL3, CCR5 ligands, is associated with the shift of HIV infection from macrophage to the T cell tropic ([@B129]; [@B104]; [@B206]).

HBZ also plays a crucial role in the pathogenesis of ATL and HAM/TSP ([@B169]; [@B44]). It has been shown that HBZ interacts with cAMP response element-binding protein (CREB) transcription factor, suppresses the Tax-mediated transactivation, and inhibits the canonical NF-kB pathway ([@B50]; [@B99]; [@B222]). It has been reported that HBZ induces the production of CCL21 and CCR4 in HTLV-1 infected cells, therefore, supporting the proliferation and migration of infected T cells ([@B185]; [@B136]).

HTLV-1 also incorporates viral protein Tax, and viral mRNAs including Tax, HBZ, and env, into exosomes derived from infected cells, which contribute to enhanced cellular FLICE-like inhibitory protein (cFLIP)-dependent survival of the recipient cell with induction of NF-kB, and resistance to apoptosis, by activation of AKT. Therefore, the exosomes derived from HTLV-1 infected cells might associate with HTLV-1 pathogenesis ([@B76]).

Chemokines and Ham/Tsp Pathogenesis {#S4}
===================================

In HAM/TSP patients, CD4^+^ CD25^+^ CCR4^+^ Foxp3^--^ T cells which serve as reservoirs for HTLV-1 ([@B212]), express low levels of TGF-β and IL-10, while they express high levels of IFN-γ, thus, this pattern of cytokine production may contribute to disease pathogenesis ([@B212]; [@B150]). High levels of the proinflammatory cytokines, chemokines, and MMP in HAM/TSP patients, is likely to be associated with HAM/TSP pathogenesis ([@B23]; [@B100]). The frequency of HTLV-1 specific CTLs is higher in HAM/TSP patients compared to ACs ([@B42]; [@B92]). These CTLs express chemokine receptors with high migratory capacity ([@B24]) involved in the migration of leukocytes to the site of inflammation and might play a crucial role in the pathogenesis of HAM/TSP. The neurological damages in CNS of HAM/TSP patients is caused by recognition of CD4^+^HTLV-1 infected cells in the CNS cells by specific CD8^+^ CTL, resulting in the production of inflammatory cytokines such as IFN-γ, TNF-α and MMP ([@B74]; [@B207]; [@B93]; [@B199], [@B201]). Furthermore, the interaction between HTLV-1-specific CTL and HTLV1-infected CD4+ T cells leads to apoptosis in surrounding neural cells such as oligodendrocytes and finally demyelination of the CNS ([@B65]; [@B60]). Further studies have demonstrated that chemokines might contribute to the HAM/TSP pathogens and we summarize their results. According to the potential ability of chemokines to direct leukocyte trafficking, homing, and migration, in this study chemokines and their receptors are further classified based on their function.

Trafficking {#S4.SS1}
-----------

### CXCL9 and CXCL10 {#S4.SS1.SSS1}

CXCL9 and CXCL10 induce the recruitment of CXCR3 expressing cells including the CXCR3^+^ IFN-γ producing HTLV-1 infected CD4^+^ T cells that promote the production of CXCL10 by the astrocytes, creating a positive feedback loop that results in the CNS chronic inflammation ([@B49]). In Multiple Sclerosis (MS), which is also a demyelinating neuroinflammatory disease, it is thought that CXCL9 and CXCL10 in the CSF are involved in the recruitment of CXCR3^+^ T cells into CNS and contribute to MS pathogenesis ([@B132]; [@B32]; [@B203]; [@B89]).

CXCL9 and CXCL10 are presented in high levels in serum and CSF of patients with HAM/TSP and contribute to the pathogenesis of HAM/TSP ([@B165]; [@B55]). Chaves et al. showed that the plasma levels of CXCL8 and CXCL9 were greater in HAM/TSP patients compared to carriers ([@B31]). Moreover, a correlation was observed between plasma levels of CXCL8, CXCL9, and CXCL10 and proviral load, in which the HTLV-1 infected individuals with higher proviral loads had increased plasma levels of these chemokines ([@B31]). CXCL10 in the CSF, as indicators of CNS inflammation, correlate with disease progression and has been suggested as a candidate for the prognosis of HAM/TSP development ([@B56]; [@B165]; [@B102]). These markers might even be more potent than the proviral load for the prediction of disease progression in HTLV-1 infected individuals ([@B165]). Elevated CSF and serum levels of CXCL9 and CXCL10, compared to carriers, alongside low levels of CCL2 are considered as pivotal markers of HAM/TSP ([@B56]; [@B165]; [@B183]; [@B102]). [@B6] showed that the production of both CXCL9 and CCL5 is elevated in HTLV-1 infected subjects compared with HCs. This high chemokine production might lead to increased inflammation in HTLV-1 infected individuals.

[@B167] showed that according to the concentrations of CSF CXCL10 and neopterin levels, HAM/TSP patients are classified into three groups based on disease activity and clinical progression rate. Further studies showed that low-dose oral prednisolone maintenance therapy decreased the CSF CXCL10 levels and is associated with good functional prognosis, suggesting CSF CXCL10 is a promising surrogate marker for HAM/TSP treatment ([@B186]).

### CXCL8 {#S4.SS1.SSS2}

CXCL8 might be associated with BBB disruption through the attraction of neutrophils within the CNS ([@B31]). CXCL8 and its receptors, CXCR1 and CXCR2, are involved in the infiltration of leukocytes into the CNS ([@B5]). CXCR1 and CXCR2 are expressed on neutrophils, monocytes, NK cells, CD4^+^ and CD8^+^T cells ([@B33]; [@B196]). CXCR2 has a role in inflammation and myelin disorders ([@B30]). The levels of CXCR2 and its ligands are elevated in various CNS inflammatory conditions ([@B64]). CXCR2 mRNA is highly expressed in HAM/TSP and CXCR2 CD8^+^ T cells have high frequencies in HAM/TSP patients. The high frequency of CXCR2 CD8^+^ T cells in HAM/TSP may contribute to demyelination and inflammation. However, CXCR1 CD8^+^ T cells are lower in HAM/TSP patients when compared to ACs. Since there is a negative correlation between proviral load and the percentage of T cells expressing CXCR1, it has been suggested that the high frequency of CXCR1 CD8^+^ T cells in ACs is associated with an efficient cell-mediated immune response that leads to limiting the spread of the virus ([@B153]). Thus, CXCL8, CXCL9, and CXCL10 are thought to be associated with HAM/TSP pathogenesis as well.

### CCL2 {#S4.SS1.SSS3}

CCL2 is thought to be associated with the migration of T cells and monocytes into the CNS of HAM/TSP patients. In HAM/TSP patients, CCL2, expressed in the CNS from vascular endothelial cells and mononuclear cells which have been infiltrated into the CNS, attracts T cells and monocytes into the CNS ([@B200]). The lower levels of CCL2, which polarizes the immune response toward Th2 ([@B162]), in HAM/TSP patients compared to HCs, also reflect a Th1 dominant immune response in HAM/TSP ([@B54]; [@B139]). It is likely that decreased levels of CCL2, which is associated with type two immune response, reflect the polarization of immune response toward a type 1 cytokine profile ([@B162]; [@B54]). da Silva-Malta et al. reported that -46C/C polymorphism in the antigen receptor for chemokines (DARC) is associated with leukopenia, neutropenia and lower levels of CCL2, however, this polymorphism is not a risk factor for HAM/TSP ([@B37]).

### CCL20 {#S4.SS1.SSS4}

The attraction of leukocytes to the site of inflammation may be conducted by CCL20/MIP-3α ([@B158]). HTLV-1 infected individuals may develop inflammatory diseases according to CCL20 expression in HTLV-1 infected and uninfected T cells, which are induced by Tax through the NF-kB pathway. Since HTLV-1-infected T cells also express CCR6, the CCL20 receptor, an autocrine/paracrine mechanism may be involved in the pathogenesis of HTLV-1 associated diseases ([@B67]; [@B151]). CCL20 is also a potent chemokine for the attraction of DCs into the CNS, suggesting infected DCs might play pivotal roles in HAM/TSP pathogenesis by induction of autoreactive T cells ([@B67]).

### CCL1 {#S4.SS1.SSS5}

The role of CCL1 in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) has been clearly investigated. It has been demonstrated that proteolipid protein-specific T-cell clones and production of the murine CCL1 homolog associates with EAE ([@B94]; [@B192]). CCL1 is mainly produced by HTLV-1 infected cells of HAM/TSP patients in a Tax inducible and dependent manner and CCR8, the specific CCL1 receptor, is expressed on both HTLV-1 infected and uninfected T cells. The production of CCL1 is dependent on CREB and AP1 and the plasma levels of CCL1 are higher in HAM/TSP patients than the carriers and healthy subjects ([@B161]). The CCL1-CCR8 signaling axis may contribute to the pathogenesis of HAM/TSP, which might be suggested as a potential therapeutic target for immunotherapy of the disease ([@B161]).

### CXCL11 {#S4.SS1.SSS6}

CXCL11 or Interferon inducible T cell alpha chemoattractant (ITAC) enhances the chemotaxis of activated T cells and NK cells and its gene expression is induced by IFN-γ. CXCR3, the CXCL11 receptor, is also highly expressed on activated T cells, memory T cells, and NK cells and IFN-γ promotes its gene expression. It is also reported that CXCL11 is involved in the pathogenesis of cell mediated immunity ([@B132]). HAM/TSP patients have high levels of CXCL11 in plasma and CSF and the CSF CXCL11 can be used as a predictor of HAM/TSP development ([@B155]; [@B156]).

Homing {#S4.SS2}
------

### CCR4 {#S4.SS2.SSS1}

CCR4^+^ T cells are selectively infected by HTLV-1 and converted into abnormal cells leading to the chronic inflammation in HAM/TSP patients ([@B10]; [@B213]). Elevated frequency of IFN-γ producing HTLV-1 infected CD4^+^CD25^+^CCR4^+^ T cells with proinflammatory features is found in HAM/TSP patients and this is associated with the disease pathogenesis ([@B10]; [@B213]). HTLV-1 induces transcriptional changes via Tax in infected T cells and downregulates the expression of FOXP3 in CD4^+^CD25^+^CCR4^+^ Tregs to lose expression of the transcription factor FOXP3 and increases the production of IFN-γ in these cells, which in turn leads to development of inflammation ([@B10], [@B11]). The HTLV-1 Tax-expressing infected CD4^+^CD25^+^CCR4^+^ T cells exert changes in infected cells that may phenotypically become IFN-γ producing Th1-like cells, which probably enhance the inflammatory state ([@B10], [@B11]). HBZ play a pivotal role in HAM/TSP by increasing the number of inducible Treg cells (iTreg) and induction of IFN-γ production ([@B211]). Administration of Mogamulizumab/KW-0761, as a humanized anti-CCR4 monoclonal antibody (mAb), in HAM/TSP, has reduced the number of HTLV-1 infected cells and inflammatory markers. However, it was accompanied by adverse effects including rash, lymphopenia and leukopenia ([@B166]).

Migration {#S4.SS3}
---------

### CCL3/MIP-1α and CCL4/MIP-1β {#S4.SS3.SSS1}

MIP can be selectively expressed and secreted in a *tax* transfected Jurkat cell line ([@B176]). Elevated levels of MIP has been also demonstrated in the CSF of HAM/TSP patients ([@B121]). HTLV-1-transformed T cells released CCL3/MIP-1α as a major monocyte chemoattractant, suggesting this molecule might play a pivotal role in the outcome of HTLV-1-related-diseases ([@B20]).

In addition to Monocyte chemoattraction ([@B170]), CCL3 and CCL4 may attract CD8^+^ and CD4^+^ T cells ([@B189]). HTLV-1 specific CTLs produce CCL3 and CCL4, which may be related to inflammation, observed in HAM/TSP patients ([@B23]).

Chemokines and ATL Pathogenesis {#S5}
===============================

ATL is an aggressive peripheral T cell neoplasm associated with HTLV-1 ([@B148]; [@B217]). ATL generally has a very poor prognosis and shorter overall survival (OS) compared to other peripheral T cell lymphoma (PTCL) ([@B204]). Clonal proliferation of HTLV-1 infected CD4^+^ T cells mediated by HTLV-1 viral factors, specifically Tax and HBZ promotes cellular transformation and leads to the development of ATL ([@B187]; [@B182]; [@B169]). Tax is able to stimulate cell proliferation in ATL and inhibits cell apoptosis ([@B216]; [@B114]; [@B131]). In fact, Tax induces expression of anti-apoptotic proteins and genes which are involved in cell proliferation and consistently inactivates tumor suppressor proteins ([@B216]; [@B114]; [@B131]). The increased cellular proliferation along with inhibited apoptosis results in prolonged cell survival and transformation of HTLV-1 infected cells ([@B216]). Since Tax is HTLV-1 specific major antigen that is recognized by CTLs, expression of Tax is lost in most of the ATL cases in order to escape host immune response ([@B83]). Despite Tax that is inactivated in most of the cases, HBZ is always expressed in all cases and plays an important role in leukemogenesis of HTLV-1 infected cells ([@B169]). In fact, Tax associates with the initiation of transformation, while HBZ is needed to maintain the transformation when Tax is silenced ([@B108]). HBZ also contributes to ATL oncogenesis by inhibition of apoptosis and supporting the proliferation and migration of ATL cells ([@B107]). The process of tissue infiltration of ATL cells and HTLV-1 infected T cells is likely to be regulated by chemokines, chemokine receptors, and adhesion molecules ([@B128]; [@B185]). Here, we focus on chemokines and chemokine receptors involved in tissue infiltration of HTLV-1 infected and enhancement of proliferation, survival, and immortalization of ATL cells.

Trafficking {#S5.SS1}
-----------

### CCL1/I-309 and CCR8 {#S5.SS1.SSS1}

CCL1/I-309 is a chemokine with the ability of monocyte attraction ([@B119], [@B120]). CCL1 observed in the supernatant of cultured ATL cells exerts anti-apoptotic effects against ATL cells ([@B159]). In addition to CCL1 production, ATL cells also express CCR8, the CCL1 chemokine receptor ([@B159]). The resistance of ATL cells to apoptosis might be attributed to the consequence of an autocrine loop between CCL1 and CCR8 ([@B159]).

### CCL2/MCP-1 {#S5.SS1.SSS2}

The elevated levels of monocyte chemoattractant protein 1 (MCP-1)/CCL2 mRNA in HTLV-1-infected T cell lines compared with uninfected cells have been reported ([@B128]). It is also shown that Tax induces the endogenous CCL2 through activation of the 5′ transcriptional regulatory region of the CCL2 gene in the human Jurkat T -cell line ([@B128]). Tax induces NF-κB binding to both CCL2 κB sites in order to transactivate the CCL2 gene via induction of NF-κB. Thus, the CCL2 gene regulation is disrupted by Tax and CCL2 is constitutively expressed in HTLV-1-infected cells ([@B128]). CCL2 also modulates the expression of leukocyte adhesion molecules and thus associates with tissue infiltration of leukocytes. Therefore, high levels of CCL2 expression in ATL cells may affect cell adhesion and tissue infiltration of ATL cells ([@B79]). These findings might have important implications for our understanding of HTLV-1-associated diseases.

Homing {#S5.SS2}
------

### CXCL12/SDF-1 α and CXCR4/CXCR7 {#S5.SS2.SSS1}

The interaction between stromal cell-derived factor 1 (SDF1)/CXCL12 and CXCR4 has been identified to play a paramount role in the migration of ATL cells ([@B9]). Expression of CXCL12 in HTLV-1 infected T cell lines have been proven to be induced by Tax ([@B9]). It was also demonstrated that Tax enhances the CXCL12/CXCR4 axis in ATL cells ([@B197]; [@B86]). Additionally, ADM3100 which serves as a CXCR4 antagonist prevents migration of human ATL cells and primary murine lymphoblastoid (pML) cells toward CXCL12 and also inhibits organ infiltration by lymphomatous cells in severe combined immunodeficient (SCID) mice ([@B86]). However, a study by [@B61] showed that the intensity of CXCR4 expression is regardless of ATL tissue infiltration.

Another chemokine receptor which is overexpressed in HTLV-1 infection is CXCR7 ([@B80]). CXCR7 serves as the CXCL12 receptor and is frequently expressed by various tumor cell lines and is also supposed to support cell survival and growth ([@B28]; [@B69]; [@B205]). CXCR7 has been shown to be expressed on some human PBMCs including B cells, monocytes and DCs, while T cells mostly lack expression of CXCR7 ([@B28]; [@B69]; [@B205]). Although CXCR7 is not expressed on T cells ([@B28]), a study by [@B80] showed that CXCR7 expression on T cells is induced by Tax, suggesting contributes in enhancement of cell survival, growth, and immortalization of HTLV-1 infected cells. It has been shown that CCX754, the synthetic CXCR7 antagonist, inhibits the growth of HTLV-1 infected cells ([@B80]).

### CXCL8 {#S5.SS2.SSS2}

The CXCL8 mRNA expression has been detected in peripheral leukemic cells of ATL patients and in cultured HTLV-1-infected T cell lines, including HUT-102, MT-1, SALT-3, and SKT-1B ([@B127]). CXCL8 protein has also been measured in the culture medium of these cells and in the extracellular fluids of ATL patients ([@B127]). Based on these findings HTLV-1 tax gene may transactivate the CXCL8 gene through the NF-κB pathway in HTLV-1-infected cells. CXCL8 is rarely expressed in T cells, but its expression is increased in ATL cells and HTLV-1-infected cells, therefore, the potential role of CXCL8 in ATL pathogenesis remains to be determined ([@B127]).

### CCL18 {#S5.SS2.SSS3}

CCL18 is significantly expressed by DCs and mainly attracts naive T cells ([@B1]; [@B146]). Hence, it may critically be involved in the initiation of an immune response ([@B172]). A study conducted by Shimizu et al. reported that cases with HTLV-1 associated lymphadenitis type and Hodgkin's like-type significantly express high levels of CCL18 compared to the non-specific lymphadenitis subjects ([@B179]). CCL18 can be associated with an efficient immune response in ATL patients through activation and attraction of leukocytes and thus plays a pivotal role in the initiation of the immune response against ATL cells ([@B179]).

Migration {#S5.SS3}
---------

### CCL25 and CCR9 {#S5.SS3.SSS1}

The characteristic feature of ATL is organ infiltration by leukemic cells ([@B113]). ATL cells from patients with GIT involvement have been found to express high levels of CCR9 which enables ATL cells to infiltrate into intestinal mucosa where CCL25, the only ligand for CCR9, is abundantly produced ([@B202]; [@B134]). [@B134] reported that the expression of CCR9 on ATL cells is induced by Tax. Immunohistochemical studies have provided pieces of evidence that CCR9 is expressed on ATL cells that were infiltrated into GIT ([@B134]). Additionally, according to the anti-apoptotic properties of CCL25 against CCR9 expressing cells, the CCL25/CCR9 interaction axis may be involved in ATL cells immortalization process ([@B220]; [@B134]). However, the freshly isolated ATL cells have been reported to scarcely express CCR9 ([@B134]).

### CCL17/TARC, CCL22/MDC, and CCR4 {#S5.SS3.SSS2}

CCR4 is highly expressed by most of ATL cells and is involved in the invasion of ATL cells into the skin tissues ([@B218]; [@B71]; [@B62]). CCR4 is well established to be expressed on Th2 cells, Treg cells, and a fraction of memory T cells in which most of them are cutaneous lymphocyte antigen positive (CLA^+^) skin-homing memory T cells ([@B219]; [@B62]). Skin lesions are frequently observed in ATL and infiltration of ATL cells into skin can be directed by the interaction of CCR4 and its ligands, namely thymus and activation-regulated chemokine (TARC)/CCL17 as well as macrophage-derived chemokine (MDC)/CCL22 ([@B218]; [@B71]; [@B177]; [@B63]). Interestingly, a study by [@B177] demonstrated that CCR4^+^ ATL cells also produce CCR4 ligands, CCL17 and CCL22.

Tax induces CCL22 expression by infected T cells and facilitates the interaction between infected cells and CCR4^+^ uninfected cells. The efficient attraction of uninfected CCR4^+^ T cells into CCL22 expressing infected cells, alongside with formation of viral synapse results in HTLV-1 transmission, indicating that ATL cells and HTLV-1-infected T cells may originate preferentially from CCR4^+^ T cells ([@B62]). Additionally, the expression of CCR4 on HTLV-1 infected T cells is not Tax inducible. Therefore, the consistent CCR4 expression on ATL cells and HTLV-1 transformed T cells may be attributable to the perception that HTLV-1 preferentially infects CCR4^+^ T cells through the recruitment of CCR4^+^ T cells via CCL22 and/or due to some growth advantages of HTLV-1--infected CCR4^+^ T cells *in vivo* as well as *in vitro* ([@B218]). However, [@B185] showed that HBZ upregulates CCR4 expression in ATL and HTLV-1 infected cells and thus, migration and proliferation of those cells are increased, thus CCR4 may not be initially expressed on the infected cells ([@B144]). CD4^+^ FOXP3^+^ cells are observed at a high frequency in ATL patients ([@B194]). The plasma levels of CCL22 in HTLV-1 infected individuals is elevated and correlates with the frequency of FOXP3^+^ cells that express CCR4. FOXP3^+^ cells play a dual role in ATL and they enhance the suppression of immune response and reduce disease progression ([@B195]). CCL22, which is produced by HTLV-1 infected cells, may attract CD4^+^ CCR4^+^Foxp3^+^ T cells with regulatory functions ([@B195]). These CD4^+^ CCR4^+^ Foxp3^+^ T cells may retard the progression of HTLV-1 associated diseases and also contribute to the immunosuppressive state in HTLV-1 infection ([@B193]; [@B194], [@B195]).

Somatic mutations in the CCR4 gene occur in about 26% of ATL cases and might enhance cell migration toward CCL17 and CCL22 gradient which may contribute to ATL progression. Thus, CCR4 signaling plays an important role in ATL pathogenesis and it is a potential target for ATL therapy ([@B137]). Several reports demonstrated that Mogamulizumab/KW-0761, as a humanized anti-CCR4 monoclonal antibody, has a potential efficacy against relapsed CCR4^+^ ATL cases and induces a long-term survival in cases who received Mogamulizumab monotherapy ([@B209]; [@B72]). According to previous studies, Mogamulizumab has increased antibody-dependent cell cytotoxicity (ADCC) of CCR4^+^ATL cells. This cytotoxicity is thought to be mainly mediated by NK cells ([@B70]). Furthermore, a shortened form of Pseudomonas exotoxin, PE38, fused to CCL17, has been found to be able to kill HTLV-1-infected cells. This effect depends on the expression of both CCR4 and furin, a proprotein convertase, which are both elevated in HTLV-1-infected cells ([@B63]).

### CCL19/ELC, CCL21/SLC and CCR7 {#S5.SS3.SSS3}

Both EBI1-ligand chemokine (ELC)/CCL19 and secondary lymphoid-tissue chemokine (SLC)/CCL21 are well defined to play a role in the migration and homing of lymphocytes to lymphoid tissues via their common receptor, the CCR7 ([@B90]). It has been shown that CCR7 is highly expressed on ATL cells from patients with lymphoid organ infiltration, thus it seems that CCR7 may be involved in the attraction of ATL cells into lymphoid tissues ([@B61]). ATL can be further characterized by CCR7 expression within CD4^+^ CCR4^+^T cells, by which the CCR7^+^ phenotype refers to aggressive ATL, while CCR7^--^ phenotype refers to progressive indolent ATL ([@B82]). Gain-of-function mutations in CCR7 gene occurring in about 11% of ATL cases induce surface CCR7 expression and chemotaxis toward CCL19 and CCL21, and also enhances PI3K/AKT signaling, implicating the association of these activating mutations in the pathogenesis of ATL ([@B84]).

### CCL5/RANTES {#S5.SS3.SSS4}

Regulated on activation, normal T cell expressed and secreted (RANTES)/CCL5 serves as a chemotactic factor for memory T cells that are produced by HTLV-1-infected cells and ATL cells in a Tax inducible manner ([@B125]). Although CCL5 is related to Th1 cells ([@B171]), it is thought to be involved in ATL pathogenesis and tissue infiltration of infected cells, through CCR5 as its receptor ([@B125]). ATL and HTLV-1-infected cell lines produce high levels of CCL5 ([@B125]). Furthermore, HTLV-1 infected T cells have been found to particularly express the CCL5 gene as well as generate CCL5 ([@B125]). A recombinant vector containing the Tax-1 gene, *pCDNA3.1-TAX*, is also thought to be able to induce CCR5 expression in the K562 cell line ([@B58]). Furthermore, CCL5 is expressed by leukemic cells in peripheral blood and lymph nodes of ATL patients. It was shown that Tax induces the expression of CCL5 mRNA in a human Jurkat T cell line through NF-κB activation pathway ([@B125]). The increased expression of CCL5 by HTLV-1-infected T cells may contribute to pathophysiology of HTLV-1-associated diseases. However, its potential role remains to be determined.

### CCL3/MIP-1α and CCL4/MIP-1β {#S5.SS3.SSS5}

CCL3/MIP-1α and CCL4/MIP-1β are highly produced in the culture supernatant and cytoplasmic fractions of tumor-infiltrating lymphocytes ([@B188]). It has been demonstrated that proinflammatory cytokines, including TNF-α, IL-1β, and IL-6 show increased levels in ATL cells. Tax enhances CCL3 and CCL4 production in ATL cells ([@B20]; [@B188]), and it is thought that the elevated production of CCL3 and CCL4 chemokines in ATL cells might induce integrin-dependent adhesion of ATL cells to the endothelium and therefore may contribute to tissue infiltration of ATL cells. Pretreatment of ATL cells with antibodies against CCL3 and CCL4 led to a decrease of tissue infiltration of ATL cells through the reduction in integrin mediated adhesion ([@B188]).

### CX3CL1/Fractalkine {#S5.SS3.SSS6}

Fractalkine or CX3CL1 is the only member of the CX3C chemokine subfamily ([@B223]; [@B81]). CX3CL1 is found both in membrane-bound and soluble forms. The membrane-bound form acts as a chemoattractive factor and its expression is induced on endothelial cells by inflammatory cytokines ([@B19]). The CX3CL1 receptor, CX3CR1, is expressed on a number of cells including cytotoxic effector lymphocytes like NK cells and cytotoxic effector T cells, mature monocytes/macrophages, and mucosal dendritic cells, which all are involved in elimination of cancer cells ([@B19]; [@B66]). The gene expression of CX3CR1 is downregulated in ATL cells ([@B179]). In the Shimizu et al. study it was shown that the CX3CR1 expression in HTLV-1 associated subjects was lower than the non-specific lymphadenitis cases, suggesting HTLV-1 infection associates with host immunity through a reduction in the number of cytotoxic cells ([@B179]). These results proposed that downregulation of CX3CR1 plays an important part in immune response against the ATL cells.

Chemokines and Other HTLV-1-Associated Diseases {#S6}
===============================================

It is well documented that ATL is associated with severe immunosuppression and patients with ATL are prone to opportunistic infections ([@B198]; [@B27]; [@B180]). However, the immune response controlling infection in HAM/TSP patients may become more harmful and participate in HAM/TSP development ([@B12]). Changes in immune response may also be related to other HTLV-1 associated diseases. Pieces of evidence indicate that different types of skin lesions observed in HTLV-1 carriers may be associated with a distinct imbalance of inflammatory response. The serum levels of CCL5, CXCL8, CXCL9, and CXCL10 have shown alterations in HTLV-1 infected individuals with or without skin lesions. It has been reported that HTLV-1 infected cases with autoimmune lesions have elevated levels of CCL5 and CXCL8 compared to those with infectious lesions. CXCL10 level has also been found to be elevated in HTLV-1 infected subjects with autoimmune lesions compared to the cases without lesions ([@B34]). Infection of lung epithelial cells by HTLV-1 was tested by co-culturing A549 alveolar and NCIH292 tracheal epithelial cell lines with MT-2 cell line which is an HTLV-1 infected T cell line. The HTLV-1 infected lung epithelial cells produce inflammatory chemokines such as CCL2, CCL5, and CCL20 ([@B191]), which are all able to contribute to the pathogenesis of HTLV-1 associated pulmonary disorders ([@B191]).

CCL5 is highly chemotactic for memory T cells and monocytes ([@B170]). This chemokine is expressed in HTLV-1-infected cell lines and primary ATL cells and may have a role in tissue infiltration ([@B125]). Monocytes have been suggested to be involved in immune regulation and progression of HTLV-1 associated diseases ([@B40]). HTLV-1 provirus has been detected in all three subsets of monocyte (classical, intermediate, non-classical) and found to have a profound impact on surface receptors, migratory function, and the frequency of all monocyte subsets. In HTLV-1 infected subjects, classical monocytes express high levels of CCR5, CXCR3 and CX3CR1 and a correlation has been observed between the proviral load and the migratory capacity of classical monocytes toward CCL2, CCL5, and CX3CL1, suggesting that migration of monocyte into inflammatory sites is related with persistence of HTLV-1 infection and progression of HTLV-1 associated inflammatory diseases, such as Myositis, Uveitis, and HAM/TSP ([@B40]).

The levels of some chemokines including CXCL9 and CXCL10 are undetectable in neutrophils from HTLV-1 infected and uninfected subjects ([@B22]). Furthermore, although neutrophils are of the main sources of CXCL8 and CCL4, these two chemokines have similar production in neutrophils from both infected and uninfected subjects, indicating that neutrophils effector functions are not impaired in these two groups ([@B22]). Pulmonary disorders can develop in ACs as well as HTLV-1 infected patients ([@B174]; [@B214]; [@B210]; [@B138]). High levels of CCL3 and CCL5 in bronchoalveolar lavage fluid (BALF) have been detected in HTLV-1 carriers ([@B174]; [@B214]). Since CCL3 and CCL5 are involved in the attraction of T cells and memory T cells, high levels of these β-chemokines in HTLV-1 carriers may play a role in developing pulmonary disorders ([@B174]). It has been reported that in HTLV-1 positive cryptogenic fibrosing alveolitis (CFA) patients, a chronic inflammatory interstitial lung disease, the BALF levels of CCL3 ([@B190]; [@B115]) and CXCL10, T cell chemoattractants and activators ([@B105]; [@B115]), are higher than those of without HTLV-1 infection. Furthermore, CCL3 and CXCL10 BALF levels were associated with an increased number of activated T cells. Moreover, HTLV-1 infection may also contribute in the development of CFA ([@B115]).

HTLV-1 infected individuals with overactive bladder, have similar serum concentrations of CXCL9 and CXCL10 compared to the carriers ([@B164]). Adding exogenous IL-10 and TGF-β to the cell cultures from HTLV-1 overactive bladder patients decreased the production of IFN-γ ([@B164]). The proviral load and levels of some immunological factors such as TNF-α and IL-17 in overactive bladder patients are similar to HAM/TSP patients. According to these observations, the overactive bladder is a common condition between carriers and HAM/TSP patients, and it was proposed that patients with overactive bladder may further develop HAM/TSP ([@B164]). [Supplementary Table 1](#TS1){ref-type="supplementary-material"} represents the chemokines and chemokine receptors associated with HTLV-1 pathogenesis.

The following issues influence the limitation of the present review including: omission of relevant research, the authors' point of view, and misconception in the translation of data from the primary literature. Controversial results of the study may have been observed due to an analysis of chemokine levels in serum/plasma, CSF and supernatant of HTLV-1 cell lines and PBMCs culture, sample size, disease duration, clinical status and heterogeneity of patients and HTLV-1 carriers. To the best of our knowledge, this review has been one of the first attempts to thoroughly explain the role of chemokines and their receptors in HTLV-1 infection; as such, a wide range of data regarding the chemokines and receptors are a strength of the study.

In this study, the status of chemokines and chemokine receptors was discussed in HTLV-1 infection focusing on two major diseases associated with the virus: ATL and HAM/TSP. According to the available studies reviewed in this work, it is clear that chemokines play a critical role in inflammation and regulating the trafficking, migration, and tissue infiltration of leukocytes, and the dysregulation of various chemokines could play an important role in the pathophysiology of HTLV-1 associated disease. Clinical studies in HAM/TSP and ATL patients have been provided promising results to be hopeful to develop and recommend more effective inhibitors of chemokines and their receptors. Therefore, development of chemokine-directed therapeutic strategies for targeting leukocyte recruitment pathways could be a promising therapeutic approach for HTLV-1 infection.

Conclusion {#S7}
==========

In this review, we have discussed the potential role of chemokines and their receptors in the outcome of HTLV-1 associated diseases. A great number of chemokines and their respective receptors have been implicated in the migration of HTLV-1 infected cells into CNS and skin lesions are a vital aspect in pathogenesis of HTLV-1-associated disease. Elevation of chemokines levels in serum and CSF in HTLV-1 infection has been considered as prognostic biomarkers and a promising surrogate marker for HAM/TSP treatment. The complexity of the chemokine network is perplexing. Thus, further investigation is required to target chemokine network that could open up a new door to therapy and prophylaxis against HAM/TSP and ATL.
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ACs

:   asymptomatic carriers

BALF

:   bronchoalveolar lavage fluid

CFA

:   cryptogenic fibrosing alveolitis

CLA^+^

:   cutaneous lymphocyte antigen positive

CTCL

:   cutaneous T cell lymphoma

CTLs

:   cytotoxic T lymphocytes

ELC

:   EBI1 ligand chemokine

FOXP3

:   Forkhead Box P3

GIT

:   gastrointestinal tract

GPCRs

:   G Protein--Coupled Receptors

HBZ

:   HTLV-1 bZIP factor

HCs

:   healthy controls

IL

:   interleukin

IP-10

:   IFN- γ inducible Protein-10

LFA-1

:   lymphocyte function-associated antigen 1

MCP-1

:   monocyte chemotactic protein-1

MDC

:   macrophage-derived chemokine

MIP

:   macrophage inflammatory protein

pML

:   primary murine lymphoblastoid

RANTES

:   regulated on activation normal T expressed and secreted

SCID

:   severe combined immunodeficiency

SDF-1 α

:   Stromal cell-Derived Factor-1

SLC

:   secondary lymphoid-tissue chemokine

TARC

:   thymus activation-regulated chemokine.
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